Cryptosporidiosis: Laboratory investigations and chemotherapy

Advances in Parasitology

Volumn 40, Issue , 1998, Pages 187-221

  Tzipori, S ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCCIDIOSTATIC AGENT; NITAZOXANIDE; PAROMOMYCIN; SECRETORY IMMUNOGLOBULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL CULTURE; CHEMOTHERAPY; CLINICAL TRIAL; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE CONTROL; DRUG DESIGN; DRUG SCREENING; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; LABORATORY; META ANALYSIS; MOUSE; NONHUMAN; OOCYST; PARASITE LOCALIZATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

CRYPTOSPORIDIUM PARVUM; PROTOZOA;

EID: 0032472044     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-308X(08)60121-9     Document Type: Article

References (153)

1. R.B. Adams R.L. Guerrant S. Zu G. Fang J.K. Roche Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model. The Journal of Infectious Diseases 169 1994 170 177
2. G. Alpert L.M. Bell C.E. Kirkpatrick L.D. Budnick J.M. Campos H.M. Friedman S.A. Plotkin Cryptosporiodiosis in a day-care center. New England Medical Journal 311 1984 860 861
3. B.C. Anderson Pattern of shedding of cryptosporidial oocysts in Idaho calves. Journal of the American Medical Association 178 1981 865 867
4. B.C. Anderson T. Donndelinger R.M. Wilkins J. Smith Cryptosporidiosis in a veterinary student. Journal of the American Veterinary Medical Association 180 1982 408 409
5. F.M. Apter P. Michetti L.S. Winner III J.A. Mack J.J. Mekalanos M.R. Neutra Analysis of the roles of anti-lipopolysaccharide and anti-cholera toxin IgA antibodies in protection against Vibrio cholerae and cholera toxin using monoclonal IgA antibodies in vivo. Infection and Immunity 61 1993 5279 5285
6. R.A. Argenzio J.A. Liacos M.L. Levy D.J. Meuten J.G. Lecce D.W. Powell Villous atrophy, crypt hyperplasia, cellular infiltration, and impaired glucose-Na absorption in enteric cryptosporidiosis of pigs. Gastroenterology 98 1990 1129 1140
7. R.A. Argenzio J. Lecce D.W. Powell Prostanoids inhibit intestinal MaCl absorption in experimental porcine cryptosporidiosis. Gastroenterology 104 1993 440 447
8. R.A. Argenzio J.M. Rhoads M. Armstrong G. Gomez Glutamine stimulates prostaglandin-sensitive Na(+)-H+ exhange in experimental porcine cryptosporidiosis. Gastroenterology 106 1994 1418 1428
9. R.A. Argenzio M. Armstrong J.M. Rhoads Role of the enteric nervous system in piglet Cryptosporidiosis. The Journal of Pharmacology and Experimental Therapeutics 279 1996 1109 1115
10. M.J. Arrowood C.R. Sterling Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. Journal of Parasitology 73 1987 314 319
11. M.J. Arrowood M.R. Hurd J.R. Mead A new method for evaluating experimental cryptosporidial parasite loads using immunofluorescent flow cytometry. Journal of Parasitology 81 1995 404 409
12. F.M. Awad-El-Kariem D.C. Wahurst V. McDonald Detection and species identification of Cryptosporidium oocysts using a system based on PCS and endonuclease restriction. Parasitology 109 1994 19 22
13. P. Bannister R.A. Mountford Cryptosporidium in the elderly: a cause of life-threatening diarrhoea. American Journal of Medicine 86 1989 507 508
14. A. Baskerville A.D. Ramsay G.H. Millward-Sadler R.W. Cook M.P. Cranage Chronic pancreatitis and biliary fibrosis associated with cryptosporidiosis in simian AIDS. Journal of Comparative Pathology 105 1991 415 421
15. Y. Benhamou N. Kapel C. Hoang H. Matta D. Meillet D. Magne M. Raphael M. Gentilini P. Opolon J.-G. Gobert Inefficacy of intestinal secretory immune response to Cryptosporidium in aquired immunodefiency syndrome. Gastroenterology 108 1995 627 635
16. F. Bissuel L. Cotte M. Rabodonirina P. Rougier M.A. Piens C. Trepo Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clinical Infectious Diseases 18 1994 447 449
17. E.K. Black G.R. Finch R. Taghi-Kilani M. Belosevic Comparison of assays for Cryptosporidium parvum oocysts viability after chemical disinfection. FEMS Microbiology Letters 135 1996 187 189
18. B.L. Blagburn C.A. Sundermann D.S. Lindsay J.E. Hall R.R. Tidwell Inhibition of Cryptosporidium parvum in neonatal Hsd: (ICR) BR Swiss mice by polyether ionophores and aromatic amidines. Antimicrobial Agents and Chemotherapy 35 1991 1520 1523
19. J.L. Blanchard G.B. Baskin M. Murphey-Corb L.N. Martin Disseminated cryptosporidiosis in simian immunodeficiency virus/delta-infected rhesus monkeys. Veterinary Pathology 24 1987 454 456
20. C. Blanshard A.M. Jackson D.C. Shanson N. Francis B.G. Gazzard Cryptosporidiosis in HIV-seropositive patients. Quarterly Journal of Medicine, New Series 85 1992 813 823
21. D.A. Blewett Quantitative techniques in Cryptosporium research. Proceedings of the 1st International Workshop on Cryptosporidiosis 1988 Angus and Blewett Edinburgh
22. P. Brasseur D. Lemeteil J.J. Ballet Rat model for human cryptosporidiosis. Journal of Clinical Microbiology 26 1988 1037 1039
23. P. Brasseur D. Lemeteil J.J. Ballet Anticryptosporidiosis drug activity screened with an immunosuppressed rat model. Journal of Protozoology 38 1991 230S 231S
24. P. Brasseur L. Favennec D. Lemeteil F. Roussel J.J. Ballet An immunosuppressed rate model for evaluation of anti-Cryptosporidium activity in sinefungin. Folia Parasitologica 41 1994 13 16
25. M. Buraud E. Forget L. Favennec J. Bizet J.G. Gobert A.M. Deluol Sexual stage development of Cryptosporidia in the Caco-2 cell line. Infection and Immunity 59 1991 4610 4613
26. P.J. Carsen R.L. Schut M.L. Simpson J. O'Brien E.N. Janoff Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. The Journal of Infectious Diseases 172 1995 340 345
27. W. Chen J.A. Harp A.G. Harmsen E.A. Havell Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infection and Immunity 61 1993 3548 3551
28. W. Chen J.A. Harp A.G. Harmsen Requirements for CD4+ cells and γ-interferon in resolution of established Cryptosporidium parvum infection in mice. Infection and Immunity 61 1993 3928 3932
29. R. Cordell D. Addiss Cryptosporidiosis in child care settings: a review of the literature and recommendations for prevention and control. Pediatric Infectious Disease Journal 13 1994 310 317
30. A.H. Cory T.C. Owen J.A. Barltrop J.G. Cory Use of aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Communications 3 1991 207 212
31. G. Cozon F. Biron M. Jeannin D. Cannella J.-P. Revillard Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. The Journal of Infectious Diseases 169 1994 696 699
32. W.L. Current Techniques and laboratory maintenance of Cryptosporidium. J.P. Dubey C.A. Speer R. Fayer Cryptosporidiosis of Man and Animals 1990 CRC Press Boston 31 49
33. L. Current L.S. Garcia Cryptosporidiosis. Clinical Microbiology Reviews 4 1991 325 358
34. W.L. Current T.B. Haynes Complete development of Cryptosporidium in cell cultures. Science 224 1984 603 605
35. W.L. Current N.C. Reese A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. Journal of Protozoology 33 1986 98 108
36. W.L. Current N.C. Reese J.V. Ernst W.S. Bailey M.B. Heyman W.M. Weinstein Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. New England Journal of Medicine 308 1983 1252 1257
37. R. Dagan D. Fraser Y. El-On I. Kassis R.J. Deckelbaum S. Turner Evaluation of an enzyme-immunoassay for detection of Cryptosporidium spp. in stool specimens from infants and young children. American Journal of Tropical Medicine and Hygiene 52 1995 134 138
38. L.J. Davis R.E. Soave R.E. Dudley J.W. Fessel S. Faulkner J.P. Mamaxos Nitazoxanide (NTZ) for AIDS-related Cryptosporidia diarrhea (CD): an open-label safety, efficacy and pharmacologic study. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans LM50 1996 289 September 1996, abstract
39. H. Denton S.M.A. Brown C.W. Roberts J. Alexander V. McDonald K. Thong G.H. Coombs Comparison of the phosphofructokinase and pyruvate kinase activities of Cryptosporidium parvum, Eimeria tenella and Toxoplasma gondii. Molecular and Biochemical Parasitology 76 1996 23 29
40. H.L. DuPont C.L. Chappel C.R. Sterling P.O. Okhuysen J.B. Rose W. Jaku-bowski The infectivity of Cryptosporidium parvum in healthy volunteers. New England Journal of Medicine 332 1995 855 859
41. B.M. Dutia M.C. Frame J.H. Subak-Sharpe W.N. Clark H.S. Marsden Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature 321 1986 439 441
42. M.T. Eggleston M. Tilley S.J. Upton Enhanced development of Cryptosporidium parvum in vitro by removal of oocyst toxins from infected cell monolayers. Proceedings of the Helminthology Society, Washington 61 1994 118 121
43. M. Egraz-Bernard L. Favennec P. Agnamey J.J. Ballet P. Brasseur Inhibition of complete development of Cryptosporidium parvum in Caco-2 cells. Letters 15 1996 897 899
44. F.J. Enriquez J. Palting J. Hensel M.W. Riggs Immunotherapy of cryptosporidiosis using IgA monoclonal antibodies to neutralizing-sensitive C. parvum antigens. 49th Meeting of the Society of Protozoologists, Tuscon, AZ, abstract 162 1996 123
45. R. Fayer W. Ellis Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice. Journal of Parasitology 79 1993 553 558
46. R. Fayer W. Ellis Paromomycin is effective as prophylaxis for cryptosporidiosis in dairy calves. Journal of Parasitology 79 1993 111 114
47. R. Fayer C. Andrews B.L. Ungar P.B.L. Blagburn Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. Journal of Parasitology 75 1989 393 397
48. R. Fayer A. Guidry B.L. Blagburn Immunotherapeutic efficacy of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice. Infection and Immunity 58 1990 2962 2965
49. G.M. Feregrino R.F. Higuera J.F. Rossignol R. Cavier C. Villarreal O.J. Padierna H. Hidalgo Extraordinary potency of the Nitozoxanida, a new antiparasitary against the Cryptosporium infections in advanced AIDS. XI International Conference on AIDS, Vancover. 1996
50. G.R. Finch C.W. Daniels E.K. Black F.W. Schaefer M. Belosevic Dose response of Cryptosporidium parvum in outbred neonatal CD-I mice. Applied and Environmental Microbiology 59 1993 3661 3665
51. T. Flanigan R. Marshall D. Redman C. Kaetzel B. Ungar In vitro screening of therepeutic agents against Cryptosporidium: hyperimmune cow colostrum is highly inhibitory. Journal of Protozoology 38 1991 225S 227S
52. T. Flanigan C. Whalen J. Turner R. Soave J. Toerner D. Havlir D. Kotler Cryptosporidium infection and CD4 counts. Annals of Internal Medicine 116 1992 840 842
53. T.P. Flanigan B. Ramratnam C. Graeber J. Hellinger D. Smith D. Wheeler P. Hawley M. Heath-Chiozzi D.J. Ward C. Brummitt J. Turner Prospective trial of paromomycin for cryptosporidiosis in AIDS. American Medical Journal 100 1996 370 372
54. D. Fourmy M.I. Recht S.C. Blanchard J.D. Puglisi Structure of the A site of Escherichia coli 165 ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274 1996 1367 1371
55. C.R. Fricker J.H. Crabb Water-borne cryptosporidiosis: detection methods and treatment. Advances in Parasitology 40 1998 237 274
56. L.S. Garcia T.C. Brewer D.A. Bruckner Fluorescence detection of Cryptosporidium oocysts in human fecal specimans using monoclonal antibodies. Journal of Clinical Microbiology 25 1987 119 121
57. R.M. Genta C.L. Chappell A.C. White J.K.T. Kimball R.W. Goodgame Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis. Gastroenterology 105 1993 1769 1775
58. A. Giacometti O. Cirioni G. Scalise In vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pryi-methamine against Cryptosporidium parvum. Journal of Antimicrobial Chemotherapy 38 1996 399 408
59. T.K. Graczyk M.R. Cranfield R. Fayer Evaluation of commercial enzyme immunoassay (EIA) and immunofluorescent antibody (FA) test kits for detection of Cryptosporidium oocysts of species other than Cryptosporidium parvum. American Journal of Tropical Medicine and Hygiene 54 1996 274 279
60. J.K. Griffiths Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment and diagnosis. Advances in Parasitology 40 1998 37 81
61. J.K. Griffiths R. Moore S. Dooley G.T. Keusch S. Tzipori Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. Infection and Immunity 62 1994 4506 4514
62. A. Guarino R.B. Canani A. Casola E. Pozio R. Russo E. Bruzzese M. Fontana A. Rubino Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. Journal of Infectious Diseases 171 1995 976 983
63. J.A. Harp J.P. Goff Protection of calves with a vaccine against Cryptos-porium parvum. Journal of Parasitology 81 1995 54 57
64. M.C. Healy S. Yang K.R. Rasmussen M.K. Jackson C. Du Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. Journal of Parasitology 81 1995 114 116
65. P. Hicks R.J. Zwiener J. Squires V. Savell Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus. Journal of Pediatrics 129 1996 297 300
66. B.D. Hill D.A. Blewett A.M. Dawson S. Wright Analysis of the kinetics, isotype and specificity of serum and coproantibody in lambs infected with Cryptosporidium parvum. Research in Veterinary Science 48 1990 76 81
67. B.D. Hill D.A. Blewett A.M. Dawson S. Wright Cryptosporidium parvum: investigation of sporozite excystation in vivo and the association of merozoites with intestinal mucus. Research in Veterinary Science 51 1991 264 267
68. D. Hockenberry G. Nunez C. Milliman R.D. Schreiber S.J. Korsmeyer Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 1990 334 336
69. M. Jenkins D. Kerr R. Fayer R. Wall Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encoding a Cryptosporidium parvum antigen. Vaccine 13 1995 1658 1664
70. A. Joe M.E.A. Pereira G.T. Keusch S. Tzipori H.D. Ward Role of a galactose-specific Cryptosporidium parvum lectin in attachment of sporozoites to host cells. Proceedings of the 95th Annual Meeting of the American Society of Microbiology, Washington, DC, abstract B-472 1995 247
71. F.J. Kaup E.M. Kuhn B. Makoschey G. Hunsmann Cryptosporidiosis of liver and pancreas in rhesus monkeys with experimental SIV infection. Journal of Medical Primatology 23 1994 304 308
72. N.W. King Simian models of acquired immunodeficiency syndrome (AIDS): a review. Veterinary Pathology 23 1986 345
73. J.P. Kraehenbuhl M.R. Neutra Monoclonal secretory IgA for protection of the intestinal mucosa against viral and bacterial pathogens. R. Ogra J. Mestecky J. McGhee J. Bienenstock M. Lamm W. Strober Mucosal Immunology 1994 Academic Press New York 403 410
74. M.A. Laxer B.K. Timblin R.J. Patel DNA sequences for the specific detection of Cryptosporidium parvum by the polymerase chain reaction. American Journal of Tropical Medicine and Hygiene 45 1991 688 694
75. M. Liuzzi R. Deziel N. Moss P. Beaulieu A. Bonneau C. Bousquet J.G. Chafouleas M. Garneau J. Jaramillo R.L. Krogsrud L. Lagace R.S. McCollum S. Nawoot Y. Guindon HSV ribonucleotide reductase with antiviral activity in vivo. Nature 372 1994 695 698
76. M.J. Lorenzo-Lorenzo E. Ares-Mazas I. Villacorta Martinez de Maturana Detection of oocysts and IgG antibodies to Cryptosporidium parvum in asymptomatic adult cattle. Veterinary Parasitology 47 1993 9 15
77. P. Ma T.G. Villanueva D. Kaufman J.F. Gillooley Respiratory cryptosporidiosis in the acquired immune deficiency syndrome. Use of modified cold Kinyoun and Hemacolor stains for rapid diagnoses. Journal of the American Medical Association 252 1984 1298 1301
78. W.R. MacKenzie N.J. Hoxie M.E. Prctor M.S. Gradus K.A. Blair D.E. Peterson J.J. Kazmierczak D.G. Addiss K.R. Fox J.B. Rose A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. New England Journal of Medicine 331 1994 161 167
79. R. Mancassola J.M. Reperant M. Naciri C. Chartier Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study. Antimicrobial Agents and Chemotherapy 39 1995 75 78
80. R.J. Marshall T.P. Flanigan Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line. Journal of Infectious Diseases 165 1992 772 774
81. V. McDonald R. Stables D.C. Warhurst M.R. Barer D.A. Blewett H.D. Chapman G.M. Connolly P.l. Chiodini K.P.W.J. McAdam In vitro cultivation of Cryptosporium parvum and screening for anticryptosporidial drugs. Antimicrobial Agents and Chemotherapy 34 1990 1498 1500
82. J.R. Mead X. You J.E. Pharr Y. Belenkaya M.J. Arrowood M.T. Fallon R.F. Schinazi Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis. Antimicrobial Agents and Chemotherapy 39 1995 854 858
83. E. Mertens Pyrophosphate dependent phosphofructokinase, an anaerobic glycolytic enzyme. FEBs Letters 288 1991 1 5
84. P. Michetti M.J. Mahan J.M. Slauch J.J. Mekalanos M.R. Neutra Monoclonal secretory IgA protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infection and Immunity 60 1992 1786 1792
85. R.A. Miller M.A. Brondson W.R. Morton Experimental cryptosporidiosis in a primate model. Journal of Infectious Diseases 161 1990 312 315
86. H. Mohri H. Fujita Y. Asakura K. Katoh R. Okamoto J. Tanabe J. Harano T. Noguchi Y. Inayama T. Amano T. Okubo Case report: therapy of paromomycin in effective for respiratory infection and hypoxia by Cryptosporidium with AIDS. American Journal of Medical Science 309 1995 60 62
87. R. Moore S. Tzipori J. Griffiths K. Johnson I. Lomakina Temporal changes in permeability of piglet ileum after site-specific infection by Cryptosporidium parvum. Gastroenterology 108 1995 1030 1039
88. M.A. Neill S.K. Rice N.V. Ahmad T.P. Flanigan Cryptosporidiosis: an unrecognized cause of diarrhea in elderly hospitalized patients. Clinical Infectious Diseases 22 1996 167 170
89. M. Neutra R. Weltzin L. Winner J. Mack P. Michetti L. Morrison B. Fields J. Mekalanos J.P. Kraehenbuhl Identification and use of protective monoclonal IgA antibodies against viral and bacterial pathogens. J. Mestecky R. Ogra Immunology of Milk and the Neonate, Advanced Experimental Biology Medicine 1991 Plenum Press New York 179 182
90. P.J. O'Donoghue Cryptosporidium and cryptosporidiosis in man and animals. International Journal of Parasitology 25 1995 139 195
91. K.G. Osborn S. Prahalada L.J. Lowenstine M.B. Gardner D.H. Maul R.V. Henrickson The pathology of an epizootic of acquired immunodeficiency in rhesus macaques. American Journal of Pathology 114 1989 94 99
92. J.E. Peeters I. Villacorta E. Vanopdenbosch D. Vandergheynst M. Naciri E. Ares-Mazas P. Yvore Cryptosporidium parvum in calves: kinetics and immunoblot analysis of specific serum and local antibody responses (immunglobu-lin A [IgA], IgG, and IgM) after natural and experimental infections. Infection and Immunity 60 1992 2309 2316
93. J. Quilez E. Ares-Mazas C. Sanchez-Acedo E. del Cacho A. Clavel A.C. Causape Comparison of oocyst shedding and the serum immune response to Cryptosporidium parvum in cattle and pigs. Parasitol Resources 82 1996 234 529
94. J.E. Rehg Anticryptosporidial activity is associated with specific sulfonamides in immunosuppressed rats. Journal of Parasitology 77 1991 238 240
95. J.E. Rehg Anti-cryptosporidial activity of macrolides in immunosuppressed rats. Journal of Protozoology 38 1991 228s 229s
96. J.E. Rehg Anticryptosporidial activity of lasalocid and other ionophorous antibodies in immunosuppressed rats. Journal of Infectious Diseases 168 1993 1566 1569
97. J.E. Rehg A comparison of anticryptosporidial activity of paramomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. Journal of Infectious Diseases 170 1994 934 938
98. J.E. Rehg The activity of halofuginone in immunosuppressed rats infected with Cryptosporidium parvum. Journal of Antimicrobial Chemotherapy 35 1995 391 397
99. J.E. Rehg M.L. Hancock D.B. Woodmansee Characterization of cyclophosphamide-rat model of cryptosporidiosis. Infection and Immunity 55 1987 2669 2774
100. J.E. Rehg M.L. Hancok D.B. Woodmansee Characterization of a dexamethasone-treated rat model of cryptosporidial infection. Journal of Infectious Diseases 158 1988 1406 1407
101. M.W. Riggs Cryptosporidiosis in cats, dogs, ferrets, raccoons, opossums, rabbits and non-human primates. J.P. Dubey C.A. Speer R. Fayer Cryptosporidiosis of Man and Animals 1990 CRC Press Boston 113 120
102. M.W. Riggs L.E. Perryman Infectivity and neutralization of Cryptosporidium sporozoites. Infection and Immunity 55 1987 2081 2087
103. S. Rohlman V.C. Kuhls D.A. Mosier D.L. Crawford D.R. Hawkins V.L. Abrams Therapy with atovaquone for Cryptosporium parvum infection in neonatal severe combined immunodeficiency mice. Journal of Infectious Diseases 168 1993 258 260
104. J.F. Rossignol H. Maisonneuve Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections. American Journal of Tropical Medicine and Hygiene 33 1985 511 512
105. S.E. Sanford Enteric cryptosporidial infection in pigs: 184 cases; (1981-1985). Journal of American Veterinary Medical Association 190 1987 695 698
106. M. Scaglia C. Atzori G. Marchetti M. Orso R. Maserati A. Orani S. Novati P. Olliaro Effectiveness of aminosidine (paromomycin) sulfate in chronic Cryptosporidium diarrhea in AIDS patients: an open, uncontrolled, prospective clinical trial. Journal of Infectious Diseases 170 1994 1349 1350
107. D.M. Schmatz W.F. Baginsky M.J. Turner Evidence for and characterization of a mannitol cycle in Eimeria tenella. Molecular and Biochemical Parasitology 32 1989 263 270
108. C.A. Scott H.V. Smith M.M. Mtambo H.A. Gibbs An epidemiological study of Cryptosporidium parvum in two herds of adult beef cattle. Veterinary Parasitology 57 1995 277 288
109. J. Stubbe Ribonucleotide reductases. Advanced Enzymolecular Related Areas Molecular Biology 63 1990 349 419
110. P. Suresh J.E. Rehg Comparative evaluation of several techniques for purification of Cryptosporidium parvum oocysts from rat feces. Journal of Clinical Microbiology 34 1996 38
111. W.W. Tan E.K. Chapnick E.I. Abter S. Haddad E.H. Zimbalist L.I. Lutwick Paromomycin-associated pancreatitis in HIV-related cryptosporidiosis. Annals of Pharmacotherapy 29 1995 22 24
112. M. Tewari V.M. Dixit Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. Journal of Biology Chemistry 270 1995 3255 3260
113. C.M. Theodos Innate and cell-mediated immune responses to Cryptosporidium parvum. Advances in Parasitology 40 1998 83 115
114. C.M. Theodos K. Sullivan T. Gull S. Tzipori Analysis of the Cryptosporidium parvum-spscific immune response generated in healing and non-healing murine models of infection. FASEB Journal 10 1996 A1182
115. M. Tilley S. Upton Sporozoites and merozoites of Cryptosporidium parvum share a common epitope recognized by a monoclonal antibody and two-dimensional electrophoresis. Journal of Parasitology 38 1991 48S 49S
116. M. Tilley S.J. Upton R. Fayer J.R. Barta C.E. Chrisp P.S. Freed B.L. Blagburn B.C. Anderson S.M. Bernard Identification of a 15-kilodalton surface glycoprotein on sprozoites of Cryptosporium parvum. Infection and Immunity 59 1991 1002 1007
117. Y. Tsujimoto Overexpression of the human bcl-2 gene products results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proceedings of the National Academic of Sciences USA 86 1989 1958 1962
118. S. Tzipori Cryptosporidiosis in humans and in animals. Microbiological Reviews 47 1983 84 96
119. S. Tzipori The relative importance of enteric pathogens affecting neonates of domestic animals. Advances in Veterinary Science and Comparative Medicine 29 1985 103 203
120. S. Tzipori Cryptosporidiosis in perspective. Advances in Parasitology 27 1988 63 129
121. S. Tzipori J.K. Griffiths Natural history and biology of Cryptosporidium parvum. Advances in Parasitology 40 1998 5 36
122. S. Tzipori I. Campbell D. Sherwood D.R. Snodgrass A. Whitelaw An outbreak of calf diarrhoea attributed to cryptosporidial infection. Veterinary Record 107 1980 579 580
123. S. Tzipori I. Campbell T. Angus The theraputic effect of 16 anti-microbiol agents on Cryptosporidium infection in mice. Aust. J. Experimental Biology Medical Science 60 1982 187 190
124. S. Tzipori M. Smith T. Makin C. Halpin Enterocolitis in piglets caused by Cryptosporidium sp. purified from calf faeces. Veterinary Parasitology 11 1982 121 126
125. S. Tzipori W. Rand J.K. Griffiths G. Widmer J. Crabb Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clinical and Diagnostic Laboratory Immunology 1 1994 450 463
126. S. Tzipori W. Rand C. Theodos Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-γ monoclonal antibody for drug testing against Cryptosporidium parvum. Journal of Infectious Diseases 172 1995 1160 1164
127. B.L.P. Ungar Cryptosporidiosis in humans (Homo saienus). J.P. Dubey C.A. Speer R. Fayer Cryptosporidiosis of Man and Animals 1990 CRC Press Boston 60 82
128. B.L.P. Ungar J.A. Burris C.A. Quinn F.D. Finkelman New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infection and Immunity 58 1990 961 969
129. B.L.P. Ungar T.-C. Kao J.A. Burris F.D. Finkelman Cryptosporidium infection in an adult mouse model: independent roles for IFN and CD4+ T lymphocytes in protective immunity. Journal of Immunology 147 1991 1014 1022
130. S.J. Upton M. Tilley D.B. Brillhart Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiology Letters 118 1994 233 236
131. S.J. Upton M. Tilley M.V. Nesterenko D.B. Brillhart A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiology Letters 118 1994 45 50
132. S.J. Upton M. Tilley D.B. Brillhart Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells. Journal of Clinical Microbiology 33 1995 371 375
133. E. Vanopdenbosch G. Wellemans Detection of antibodies to Cryptosporidium by indirect immunofluorecensce (drop method). Prevalence of antibodies in different animal species. Vlaams Diergeneeskd Tijdschr 54 1985 49 54
134. J.R. Vazques L. Gooze K. Kim J. Gut C. Peterson R.G. Nelson Potential antifolate resistance determinants and genotypic variation in the Afunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum. Molecular and Biochemical Parasitology 79 1996 153 165
135. R. Verdon J. Polianski C. Gaudebout C. Marche L. Garry J.J. Pocidalo Evaluation of curative anticryptosporidial activity of paromomycin in a dexamethasone-treated rat model. Antimicrobial Agents and Chemotherapy 38 1994 1681 1682
136. R. Verdon G.T. Keusch S. Tzipori S.M. Grubman D.M. Jefferson H.D. Ward An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum. Journal of Infectious Diseases 1997 (in press)
137. I. Villacorta D. de Graaf G. Charleir J.E. Peeters Complete development of Cryptosporium parvum in MDBK cells. FEMS Microbiology Letters 142 1996 129 132
138. J. Vitovec B. Koudela Pathogenesis of intestinal cryptosporidiosis in conventional and gnotobioti piglets. Veterinary Parasitology 43 1992 25 36
139. E. Waldman S. Tzipori J.R.L. Forsyth Separation of Cryptosporidium species oocysts from feces by using a percoll discontinuous density gradient. Journal of Clinical Microbiology 23 1986 199
140. H. Ward A. Joe M. Kelly R. Verdon S. Tzipori M. Percira G.T. Keusch Use of ELISA-based assays to study C. parvum-host cell interaction. Abstracts of the American Society of Tropical Medicine and Hygiene Annual Meeting, San Antonio. 1995
141. K.A. Webster J.D.E. Pow M. Giles J. Catchpole M.J. Wooward Detection of Cryptosporidium parvum using a specific polymerase chain reaction. Veterinary Parasitology 50 1993 35 44
142. A.C. White C.L. Chappell C.S. Hayat K.T. Kimball T.P. Flanigan R.W. Good-game Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. Journal of Infectious Diseases 170 1994 419 424
143. G. Widmer Genetic heterogeneity and PCR detection of Cryptosporidium parvum. Advances in Parasitology 40 1998 219 235
144. G. Widmer S. Tzipori G.J. Griffiths Cryptosporidium parvum induces apoptosis in CaCo-2 and MDBK monolayers. 49th Meeting of the Society of Protozoologists, Tuscon, AZ, abstract 228 1996 143
145. L. Winner R. Mack Weltzin J. Mekalanos J.P. Kraehenbuhl M.R. Neutra New model for analysis of muscosal immunity: intestinal secretion of specific monoclonal IgA from hybridoma tumors protects against V. Cholerae. Infection and Immunity 59 1991 977 982
146. K.M. Woods M.V. Nesterenko S.J. Upton Development of a microtitre ELISA to quantify development of Cryptosporidium parvum in vitro. FEMS Microbiology Letters 128 1995 89 93
147. K.M. Woods M.V. Nesterenko S.J. Upton Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. Annals of Tropical Medicine and Parasitology 90 1996 603 615
148. D. Xue H.R. Horvitz Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377 1995 248 251
149. S. Yang M.C. Healey The immunosuppressive effects of dexamethasone administered in drinking water to C57BL/6N mice infected with Cryptosporidium parvum. Journal of Parasitology 79 1993 626 630
150. S. Yang M.C. Healey C. Du Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice. FEMS Immunology and Medical Microbiology 13 1996 141 145
151. S. Yang M.C. Healey C. Du J. Zhang Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells. Infection and Immunity 64 1996 349 354
152. N. Yarlet S.J. Upton G. Zhu J. Keithly Polyamine metabolism: a rational drug target for Cryptosporium parvum. Molecular Parasitology meeting. September. MBL, Woods Hole, MA. 1995
153. X. You M.J. Arrowood M. Lejkowski L. Xie R.F. Schinazi J.R. Mead A chemiluminescence immunoassay for evaluation of Cryptosporidium parvum growth in vitro. FEMS Microbiology Letters 136 1996 251 256